SOBERANA

2 trials

Sponsors

Instituto Finlay de Vacunas (IFV), Finlay Vaccine Institute (IFV)

Conditions

COVID-19 COVID-19 SARS-CoV2

Phase 2

SOBERANA CENTRO

Active, not recruitingRPCEC00000385

Finlay Vaccine Institute (IFV)COVID-19 COVID-19 SARS-CoV2

Start: 2021-07-26Target: 1166Updated: 2026-08-10

SOBERANA PEDIATRIA CLINICA 1

RecruitingRPCEC00000384

Instituto Finlay de Vacunas (IFV)COVID-19 COVID-19 SARS-CoV2

Start: 2021-07-17Target: 425Updated: 2026-08-10

Related Papers

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.

2022-02-0819 citations